ストックスクリーナーアプリを入手
232.74
1.18%
2.72
アフターアワーズ：
232.74
Labcorp Holdings Inc (LH) 最新ニュース
Labcorp Holdings to Announce Q1 2025 Financial Results - TipRanks
Labcorp Earnings Preview: Q1 2025 Results Coming April 29Key Updates Expected - Stock Titan
LabCorp EVP Mark Schroeder sells $610,450 in stock By Investing.com - Investing.com South Africa
Labcorp holdings EVP Amy Summy sells $175,605 in stock - Investing.com
LabCorp EVP Mark Schroeder sells $610,450 in stock - Investing.com
Baird Adjusts Labcorp Holdings Price Target to $292 From $293, Maintains Outperform Rating - MarketScreener
Labcorp 401(k) Plan Fee Class Action Gets Green Light for Trial - news.bloombergtax.com
Labcorp Denied Early Win In 401(k) Fee Suit - Law360
Is Labcorp Holdings Stock Outperforming the Nasdaq? - MSN
A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack - Yahoo Finance
Labcorp to close Los Angeles site, lay off 73 people - Yahoo Finance
Why Labcorp (LH) is a Top Growth Stock for the Long-Term - Yahoo Finance
Labcorp Holdings Inc. (NYSE:LH) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed? - simplywall.st
Labcorp is Set to Acquire Select Assets of BioReference Health of OPK - Yahoo Finance
Labcorp Warns Fed. Circ. Of 'Balkanization' In Prenatal IP Row - Law360
Labcorp’s SWOT analysis: clinical testing giant’s stock faces growth opportunities - Investing.com
Labcorp to acquire certain assets of Opko Health’s BioReference Health - Yahoo Finance
Truist remains bullish on Labcorp after ‘another nice strategic acquisition’ - Yahoo Finance
Labcorp to buy Opko unit’s cancer test assets for up to $225M - Yahoo Finance
Labcorp to acquire BioReference Health assets for up to $225M By Investing.com - Investing.com Canada
Truist maintains Buy on LabCorp stock, keeps $285 target By Investing.com - Investing.com Canada
Opko Health Sells BioReference Assets to Labcorp - TipRanks
Labcorp Announces Acquisition Of Select Assets Of Bioreference Health's Innovative Oncology And Related Clinical Testing Services Businesses - Marketscreener.com
Labcorp to buy certain assets of OPKO unit BioReference Health - MSN
Labcorp stock gains on deal to buy OPKO assets (LH:NYSE) - Seeking Alpha
Labcorp to Buy Some OPKO BioReference Assets for Up to $225 Million - MarketWatch
Labcorp To Buy Certain Assets Of BioReference Health For A Maximum $225 Mln - Nasdaq
Labcorp's $225M Oncology Testing Expansion: Strategic BioReference Assets Acquisition Promises Market Growth - StockTitan
Labcorp Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Labcorp Holdings' (NYSE:LH) Strong Earnings Are Of Good Quality - Yahoo Finance
Labcorp director Anderson sells shares for $127,817 By Investing.com - Investing.com Australia
Charles River, LabCorp upgraded, Quest downgraded at Citi on valuation - MSN
Labcorp director Anderson sells shares for $127,817 - Investing.com
Should Labcorp Stock Stay In Your Portfolio Right Now? - Barchart
Should Labcorp Stock Stay in Your Portfolio Right Now? - Nasdaq
Labcorp Faces Mixed Investor Reactions Amid Market FluctuationsNews and Statistics - IndexBox, Inc.
Citigroup Upgrades Labcorp Holdings (LH) - MSN
Labcorp Gains Citi Upgrade While Quest Diagnostics Faces Downgrade On Margin Concerns — Retail Sentiment Mixed - MSN
Labcorp’s EVP Mark Schroeder sells $1.33 million in stock By Investing.com - Investing.com South Africa
Labcorp’s EVP Mark Schroeder sells $1.33 million in stock - Investing.com India
Labcorp Holdings Insider Sold Shares Worth $1,330,639, According to a Recent SEC Filing - Marketscreener.com
What 10 Analyst Ratings Have To Say About Labcorp Hldgs - Benzinga
Citigroup Upgrades Labcorp Holdings to Buy From Neutral, Adjusts Price Target to $300 From $250 - Marketscreener.com
Fortrea Faces Spin-Related Challenges in the Near Term; Positive Long-Term Outlook - Morningstar
1.76%
1.12%
大文字化:
|
ボリューム (24 時間):